Protective immunity to type 2 dengue virus after immunization with a recombinant non-structural 1 (NS1) protein and a nontoxic heat-labile toxin (LTG33D) as adjuvant (2011)
- Authors:
- Autor USP: FERREIRA, LUIS CARLOS DE SOUZA - ICB
- Unidade: ICB
- Assunto: MICROBIOLOGIA
- Language: Português
- Imprenta:
- Publisher: Sociedade Brasileira de Microbiologia (SBM)
- Publisher place: São Paulo
- Date published: 2011
- Conference titles: Congresso Brasileiro de Microbiologia
-
ABNT
AMORIM, Jaime Henrique et al. Protective immunity to type 2 dengue virus after immunization with a recombinant non-structural 1 (NS1) protein and a nontoxic heat-labile toxin (LTG33D) as adjuvant. 2011, Anais.. São Paulo: Sociedade Brasileira de Microbiologia (SBM), 2011. . Acesso em: 05 maio 2024. -
APA
Amorim, J. H., Diniz, M. O., Cariri, F. A. M. O., Rodrigues, J. F., Bizerra, R. S., Alves, A. M. de B., & Ferreira, L. C. de S. (2011). Protective immunity to type 2 dengue virus after immunization with a recombinant non-structural 1 (NS1) protein and a nontoxic heat-labile toxin (LTG33D) as adjuvant. In . São Paulo: Sociedade Brasileira de Microbiologia (SBM). -
NLM
Amorim JH, Diniz MO, Cariri FAMO, Rodrigues JF, Bizerra RS, Alves AM de B, Ferreira LC de S. Protective immunity to type 2 dengue virus after immunization with a recombinant non-structural 1 (NS1) protein and a nontoxic heat-labile toxin (LTG33D) as adjuvant. 2011 ;[citado 2024 maio 05 ] -
Vancouver
Amorim JH, Diniz MO, Cariri FAMO, Rodrigues JF, Bizerra RS, Alves AM de B, Ferreira LC de S. Protective immunity to type 2 dengue virus after immunization with a recombinant non-structural 1 (NS1) protein and a nontoxic heat-labile toxin (LTG33D) as adjuvant. 2011 ;[citado 2024 maio 05 ] - Avaliação das propriedades imunológicas e papel vacinal da flagelina fliCi de Salmonella enterica pv Typhimurium
- Expression of enterotoxigenic Escherichia coli proteins by genetically modified Bacillus subtilis strains as a new approach to develop mucosal vaccines
- Immunogenicity of flagelins FliCi e FliCd following oral immunization of mice with attenuated salmonella strains
- Evaluation of the genetic diversity among enterotoxigenic Escherichia coli (ETEC) strains isolated from humans in Brazil and Argentina
- Construção de uma vacina de DNA bivalente contra os vírus do papiloma e herpes simplex humano
- A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 'A ind.2' and B subunits confers protective immunity to shiga toxin challenge in the murine model
- Produção e purificação da flagelina FliCi de S. Typhimurium
- Surface expression of adhesins enhances the vaccine potential of orally delivered Bacillus subtilis strains
- Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human Papillomavirus type 16 oncoproteins genetically fused to Herpesvirus glycoprotein D
- Characterization of a DNA vaccine encoding the HPV-16 E7 oncoprotein genetically fused to the N-terminal domain of Salmonella enterica SV Müenchen FLICd flagellin
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
